The Latest Breaking News from Vaccine

Measles is wildly contagious. Nearly 1 out of every 3 children under the age of 5 who catches measles ends up in the hospital.

Eligible people include those aged 75 and over, and anyone aged five and over who has a weakened immune system

Around five million people in total are eligible for a booster until the end of June.

Adding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-developers Moderna Inc. and Merck & Co. said in their first detailed presentation of a key study.

Sir John Bell and Sir David King among leading scientists to argue UK is no better prepared than it was in 2020, as new variant in India causes concern

Lyndsey Carter says her granddaughter was left 'balling her eyes out' after coming across the lifeless pup at her home just five hours after they returned from getting three puppies vaccinated

Research shows that knowing about the nocebo effect – the 'evil twin' of the placebo effect – means you are less likely to experience negative side effects of drugs or treatments, says Dr Kate MacKrill

The vaccine being used in the Spring booster campaign works in a different way to previous jabs

Back in January, an academic study gave heart to critics of COVID-19 vaccines by estimating the number of U.S. deaths from the vaccines at 278,000.

Dianne Feinstein’s return to the U.S. Senate has been delayed by complications from shingles. The risk of contracting that debilitating disease can be sharply reduced with the Shingrix vaccine, made by GSK, which has its U.S. headquarters in Philadelphia.

In the UK a spring booster campaign has recently begun, offering an additional vaccine to people at highest risk from COVID. Between April and June 2023 people aged over 75, residents in care homes and children and adults aged five and up with weakened immune systems will be invited to…